Die PRISMS-Studie Interferon-β 1a (Rebif®) bei schubförmiger multipler Sklerose
H.-P. Hartung, P. Flachenecker, F. X. Weilbach, P. RieckmannVolume:
70
Language:
german
Pages:
4
DOI:
10.1007/s001150050421
Date:
February, 1999
File:
PDF, 91 KB
german, 1999